Vincent Medical Holdings (SEHK:1612) - Aktienkurs, Nachrichten und Analyse

1612 Aktienübersicht

Vincent Medical Holdings Limited, eine Investment-Holdinggesellschaft, erforscht, entwickelt, produziert, vermarktet, handelt und verkauft medizinische Geräte.

Über das Unternehmen

1612 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	5/6
Künftiges Wachstum	2/6
Vergangene Leistung	4/6
Finanzielle Gesundheit	6/6
Dividenden	4/6

Belohnungen

79.6% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 10.43% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 19.4%

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Risikoanalyse

Unbeständige Dividendenentwicklung

Hat keine nennenswerte Marktkapitalisierung (HK$258M)

Vincent Medical Holdings Limited Wettbewerber

AMCO United Holding

SEHK:630

HK$63.9m

Gaush Meditech

SEHK:2407

HK$1.5b

Sisram Medical

SEHK:1696

HK$1.8b

PW Medtech Group

SEHK:1358

HK$1.7b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Vincent Medical Holdings
Historische Aktienkurse
Aktueller Aktienkurs	HK$0.39
52-Wochen-Hoch	HK$0.49
52-Wochen-Tief	HK$0.32
Beta	0.40
11 Monat Veränderung	-9.30%
3 Monate Veränderung	-7.14%
1 Jahr Veränderung	4.00%
33 Jahre Veränderung	-60.20%
5 Jahre Veränderung	-44.29%
Veränderung seit IPO	-58.51%

Aktuelle Nachrichten und Updates

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Aug 23

Recent updates

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Aug 23

Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

May 21

Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

Dec 21

Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Aug 29

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

May 30

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Dec 15

One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Aug 07

Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term

Jul 27

Is Vincent Medical Holdings (HKG:1612) A Risky Investment?

Jun 06

One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%

Mar 28

Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Mar 25

Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital

Mar 23

Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?

Mar 04

I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease

Feb 17

Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?

Feb 04

What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition

Jan 22

Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%

Jan 08

Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 26

What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation

Dec 14

Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?

Dec 02

Can Vincent Medical Holdings (HKG:1612) Keep Up These Impressive Returns?

Nov 20

Aktionärsrenditen

	1612	HK Medical Equipment	HK Markt
7D	-1.3%	12.7%	10.9%
1Y	4.0%	-32.6%	13.4%

Rendite im Vergleich zur Industrie: 1612 übertraf die Branche Hong Kong Medical Equipment , die im vergangenen Jahr eine Rendite von -46.5 erzielte.

Rendite vs. Markt: 1612 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von 8.2 erzielte.

Preisvolatilität

Is 1612's price volatile compared to industry and market?
1612 volatility
1612 Average Weekly Movement	5.3%
Medical Equipment Industry Average Movement	8.1%
Market Average Movement	6.8%
10% most volatile stocks in HK Market	13.7%
10% least volatile stocks in HK Market	3.5%

Stabiler Aktienkurs: 1612 hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: 1612Die wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1997	1,375	Raymond Choi	www.vincentmedical.com

Vincent Medical Holdings Limited, eine Investment-Holdinggesellschaft, erforscht, entwickelt, produziert, vermarktet, handelt und verkauft medizinische Geräte. Das Unternehmen ist in zwei Segmenten tätig: Original Equipment Manufacturing (OEM) und Original Brand Manufacturing (OBM). Das Unternehmen entwickelt medizinische Geräte mit den Schwerpunkten Beatmungsgeräte, Einwegprodukte für die Bildgebung sowie orthopädische und Rehabilitationsprodukte.

Vincent Medical Holdings Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Vincent Medical Holdings im Vergleich zum Marktanteil des Unternehmens?
1612 grundlegende Statistiken
Marktanteil	HK$254.80m
Gewinn(TTM)	HK$63.96m
Umsatz(TTM)	HK$737.44m

4.0x

Kurs-Gewinn-Verhältnis

0.3x

Kurs-Umsatz-Verhältnis

Ist 1612 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
1612 Gewinn- und Verlustrechnung (TTM)
Einnahmen	HK$737.44m
Kosten der Einnahmen	HK$496.70m
Bruttogewinn	HK$240.74m
Sonstige Ausgaben	HK$176.78m
Umsatz	HK$63.96m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	0.098
Bruttomarge	32.65%
Nettogewinnspanne	8.67%
Schulden/Eigenkapital-Verhältnis	3.3%

Wie hat sich 1612 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

8.2%

Aktuelle Dividendenrendite

31%

Ausschüttungsquote

1612 Aktienübersicht

Belohnungen

Risikoanalyse

Vincent Medical Holdings Limited Wettbewerber

SEHK:630

HK$63.9m

SEHK:2407

HK$1.5b

SEHK:1696

HK$1.8b

SEHK:1358

HK$1.7b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

First half 2024 earnings released: EPS: HK$0.052 (vs HK$0.041 in 1H 2023)

First half dividend increased to HK$0.016

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Vincent Medical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on 27 September 2024

Vincent Medical Holdings Limited to Report First Half, 2024 Results on Aug 21, 2024

Upcoming dividend of HK$0.015 per share

Recent updates

First half 2024 earnings released: EPS: HK$0.052 (vs HK$0.041 in 1H 2023)

First half dividend increased to HK$0.016

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Vincent Medical Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on 27 September 2024

Vincent Medical Holdings Limited to Report First Half, 2024 Results on Aug 21, 2024

Upcoming dividend of HK$0.015 per share

Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vincent Medical Holdings Limited, Annual General Meeting, May 22, 2024

Full year 2023 earnings released: EPS: HK$0.089 (vs HK$0.027 loss in FY 2022)

Vincent Medical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

Vincent Medical Holdings Limited to Report Fiscal Year 2023 Results on Mar 20, 2024

Vincent Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023

Executive Chairman recently bought HK$239k worth of stock

Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)

CEO & Executive Director recently bought HK$120k worth of stock

Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital

Upcoming dividend of HK$0.013 per share at 6.0% yield

First half 2023 earnings released: EPS: HK$0.041 (vs HK$0.068 loss in 1H 2022)

New minor risk - Dividend sustainability

Vincent Medical Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 29, 2023

New major risk - Revenue and earnings growth

Vincent Medical Holdings Limited to Report First Half, 2023 Results on Aug 23, 2023

Vincent Medical Holdings Limited Appoints Leung Ming Chu as Non-Executive Director

Executive Chairman recently bought HK$103k worth of stock

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Vincent Medical Holdings Limited Announces Retirement of Guo Pengcheng as Non-Executive Director

Full year 2022 earnings: EPS exceeds analyst expectations

Vincent Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022

Vincent Medical Holdings Limited Announces FDA 510(K) Clearance of the Inspired Vhb20 Heated Humidifier

Vincent Medical Holdings Limited Announces Board Changes

Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?

Now 21% undervalued

Less than half of directors are independent

Executive Chairman recently bought HK$417k worth of stock

Upcoming dividend of HK$0.025 per share

Vincent Medical Holdings Limited Announces Special Dividend for the Six Months Ended June 30, 2022, Payable on September 30, 2022

First half 2022 earnings released: HK$0.068 loss per share (vs HK$0.064 profit in 1H 2021)

One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat

Consensus revenue estimates fall by 18%

Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall

Vincent Medical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

VP of Engineering & Executive Director recently bought HK$58k worth of stock

Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended 31 December 2021

Upcoming dividend of HK$0.025 per share

Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025

Price target decreased to HK$1.30

Less than half of directors are independent

Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year

Executive Chairman recently bought HK$211k worth of stock

Consensus revenue estimates fall by 22%

Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive

Vincent Medical Holdings Limited to Report Fiscal Year 2021 Results on Mar 23, 2022

Vincent Medical Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2021

Investor sentiment improved over the past week

VP of Engineering & Executive Director recently bought HK$53k worth of stock

Executive Chairman recently bought HK$70k worth of stock

Erträge & Einnahmen